A detailed history of Angeles Wealth Management, LLC transactions in Repligen Corp stock. As of the latest transaction made, Angeles Wealth Management, LLC holds 1,907 shares of RGEN stock, worth $290,569. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,907
Previous 1,682 13.38%
Holding current value
$290,569
Previous $209,000 21.53%
% of portfolio
0.02%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025

BUY
$111.43 - $134.0 $25,071 - $30,150
225 Added 13.38%
1,907 $254,000
Q2 2025

Jul 29, 2025

BUY
$108.89 - $145.23 $183,152 - $244,276
1,682 New
1,682 $209,000
Q4 2024

Jan 28, 2025

BUY
$123.41 - $160.92 $188,323 - $245,563
1,526 New
1,526 $219,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.46B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Angeles Wealth Management, LLC Portfolio

Follow Angeles Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Angeles Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Angeles Wealth Management, LLC with notifications on news.